Effects of Capoeira on the Physical and Psychological Performance of Adults

March 22, 2024 updated by: Sérgio Rodrigues Moreira, Universidade Federal do vale do São Francisco

Effects of Capoeira Training on Physical Performance and Psychological Aspects Performance of Adults: a Randomized Controlled Clinical Trial

Regular physical activity (PA) promotes benefits for both physical and mental health. Among the numerous PA's with a collective nature that can add to the existing recommendations, combat sports training interventions are viable alternatives since they integrate benefits in different aspects for health. In this way, capoeira can be a strategy for the prescription of exercise, aiming to serve participants collectively and maintaining the adherence of this practitioner to the intervention. However, little is known about this issue. So, the aim of the present study is to verify the effect of 12 weeks of capoeira training on the physical performance and psychological aspects of previously physically inactive adults.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Enrolling by invitation

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The study will be conducted as a controlled, randomized, two-group parallel and superiority clinical trial with a 1:1 allocation ratio. The sample will be divided into two groups: 1) capoeira training group (n = 76; GCAP) and 2) control group (n = 76; GCONT). Participants aged between 18 and 59 years, classified as irregularly active A by the international physical activity questionnaire, who are not engaged in training programs and are not former athletes, will be eligible. Smokers and patients with respiratory or cardiovascular diseases will be excluded from the sample. Anamnesis and anthropometric evaluation will initially be performed. To evaluate the physical aspects, specific tests will be applied to determine aerobic and anaerobic fitness, strength and power of lower limbs, balance, motor coordination and questionnaires will be applied to verify the psychological aspects, such as emotional intelligence, motivation and quality of life. The descriptive analysis of the outcomes will be reported. The normality of the data will be checked by visual inspection of the Q-Q plot and statistically tested by the Shapiro-Wilk test. Two-way ANOVA for repeated measures will be employed to verify the time*group interaction. The effect size (ES) of the intervention on dependent variables will be calculated and the difference between the ES and its respective 95% confidence interval will be calculated to estimate the magnitude of the response in the intervention. The alpha adopted will be 5% and the software used for data analysis will be Statistical Packages for the Social Sciences 25.0.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
42

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Brazil
    • Pernambuco
      • Petrolina, Pernambuco, Brazil, 56300000
        • UNIVASF

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Classified as "irregularly active A" by the International Physical Activity Questionnaire;
  • Do not be engaged and/or have participated in the last two months of any physical training program;
  • Do not be former athletes;
  • Do not be a smoker or suffering from respiratory or cardiovascular diseases.

Exclusion Criteria:

  • Do not have musculoskeletal problems during the program that make it impossible to participate;
  • Do not participating in at least 80% of the training sessions during the intervention.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: CAPOEIRA GROUP
The training program will be conducted over 12 weeks with two weekly sessions. Each session will last 60 minutes and will be divided into three parts: 1) initial part: execution of stretches and low-intensity actions with specific movements of capoeira; 2) main part: realization of the training program the schedule present in Table 1 for the learning of attacks, dodges and acrobatic movements or flourishes and; 3) Final part: in a self-selected way in the capoeira roda, the participant will develop the previously learned movements.
Other: CAPOEIRA TRAINING
The protocol of the capoeira training program and the movements (blows, dodges and flourishes) will be based on the Capoeira Abadá method.
Active Comparator: CONTROL GROUP
The CONTROL GROUP will be conducted over 12 weeks with two weekly sessions. Each session will last 60 minutes and will be divided into three parts: 1) initial part: execution of stretches and low-intensity actions with specific movements of capoeira; 2) main part: continuation with execution of stretches and low-intensity actions with specific movements of capoeira and; 3) Final part: in a self-selected way in the capoeira roda, the participant will develop the previously learned movements.
Other: CONTROL GROUP
The protocol of the control group will be based on an intervention with capoeira movements, however, without important cardiovascular, neuromuscular and metabolic demands, being an activity with stretching movements from positions of the capoeira modality itself.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Change from baseline in aerobic fitness (maximal oxygen uptake and anaerobic threshold) at week 12
Time Frame: Baseline and week 12
The maximal oxygen uptake and anaerobic threshold are valid indicators for assessing aerobic fitness
Baseline and week 12
Change from baseline in anaerobic fitness (Peak, average and minimum power in the Wingate test) at week 12
Time Frame: Baseline and week 12
The Peak, average and minimum power in the Wingate test are valid indicators for assessing anaerobic fitness
Baseline and week 12
Change from baseline in muscle strength (Horizontal Leg Press) at week 12
Time Frame: Baseline and week 12
The methods and procedures are valid indicators for assessing muscle strength
Baseline and week 12
Change from baseline in muscle power (Vertical Jump Tests from Squat Jump and Counter Movement Jump) on force platform at week 12
Time Frame: Baseline and week 12
The methods and procedures are valid indicators for assessing muscle power
Baseline and week 12
Change from baseline in balance (Center of Pressure) on force platform at week 12
Time Frame: Baseline and week 12
The methods and procedures are valid indicators for assessing balance
Baseline and week 12
Change from baseline in motor coordination (Test of Gross Motor Development) at week 12
Time Frame: Baseline and week 12
The methods and procedures are valid indicators for assessing motor coordination
Baseline and week 12
Change from baseline in Emotional Intelligence to sport (Likert-type scales with 26 items) at week 12
Time Frame: Baseline and week 12
The methods and procedures are valid indicators for assessing Emotional Intelligence with changes 26 (worst) to 130 (better) points
Baseline and week 12
Change from baseline in Motivation for Sport II (Likert-type scales with 18 items) at week 12
Time Frame: Baseline and week 12
The methods and procedures are valid indicators for assessing Motivation for Sport with changes 1 (worst) to 7 (better) points
Baseline and week 12
Change from baseline in Quality of life measuring by Questionnaire of Word Health Organization (WHOQOL-bref) at week 12
Time Frame: Baseline and week 12
The procedures are valid indicators for assessing Quality of life (26 questions divided into four domains - physical, social, psychological, and environmental) with changes 1 (worst) to 100 (better) points
Baseline and week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Universidade Federal do vale do São Francisco

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 1, 2024

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 15, 2024

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 13, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 15, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 22, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 29, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 29, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 22, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Ethics Approval: n. 6.683.936

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Training

Clinical Trials on CAPOEIRA TRAINING

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings